YH Park

Palbociclib plus exemestane with gonadotropin-releasing hormone agonist versus capecitabine in premenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer (KCSG-BR15-10): a multicentre, open-label, randomised, phase 2 trial

Yeon Hee Park, Tae‐Yong Kim, Gun Min Kim et al. · The Lancet Oncology · 2019 · 130 citations

Medicine, Oncology, Pharmacology +16

Clinical significance of CD151 overexpression in subtypes of invasive breast cancer

Mi Kwon, S Park, Jung Yun Choi et al. · British Journal of Cancer · 2012 · 88 citations · Full text

Medicine, Oncology, Pathology +13

Establishment and characterisation of six human biliary tract cancer cell lines

J-L Ku, K-A Yoon, IJ Kim et al. · British Journal of Cancer · 2002 · 87 citations · Full text

Medicine, Genetics, Oncology +12

Infectious complications and outcomes after allogeneic hematopoietic stem cell transplantation in Korea

Yoo Jh, Su‐Mi Choi, JH Choi et al. · Bone Marrow Transplantation · 2004 · 67 citations

Medicine, Hematology, Infectious Diseases +13

Ramosetron for the Prevention of Cisplatin-Induced Acute Emesis: A Prospective Randomized Comparison with Granisetron

Y.-K. Kang, YH Park, BY Ryoo et al. · Journal of International Medical Research · 2002 · 51 citations

Medicine, Pharmacology, Pharmacotherapy +17